Benlysta
Benlysta (belimumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells helping to protect healthy cells from damage. Specifically it is a B-lymphocyte stimulator. Benlysta is used together with other lupus medicines to treat active systemic lupus erythematosus (SLE).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: GlaxoSmithKline (GSK) |
CLASS: Monoclonal Antibodies |
PRESCRIBED BY: Rheumatologists |
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Administered every two weeks for three doses, then every four weeks. |
Length of infusion: About 60 minutes |
FOR MORE INFORMATION: |